Patent
   D439325
Priority
Feb 08 2000
Filed
Feb 08 2000
Issued
Mar 20 2001
Expiry
Mar 20 2015
Assg.orig
Entity
unknown
77
9
n/a
The ornamental design for a cover for a nasal inhaler, as shown and described.

FIG. 1 is a top, front and right side perspective view of my design for a cover for a nasal inhaler in with the nasal inhaler shown in phantom;

FIG. 2 is a right side elevation view thereof;

FIG. 3 is a front elevational view thereof;

FIG. 4 is a top plan view thereof;

FIG. 5 is a rear elevational view thereof; and,

FIG. 6 is a bottom plan view thereof.

Frost, Phillip

Patent Priority Assignee Title
10130581, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
10130685, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
10130709, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
10143655, Sep 14 2005 MannKind Corporation Method of drug formulation
10159644, Oct 26 2012 MannKind Corporation; TechnoVax, Inc. Inhalable vaccine compositions and methods
10172850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
10201672, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
10258664, Oct 24 2011 MannKind Corporation Methods and compositions for treating pain
10307464, Mar 27 2015 MannKind Corporation Use of ultrarapid acting insulin
10342938, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
10421729, Mar 15 2013 MannKind Corporation Microcrystalline diketopiperazine compositions and methods
10561806, Oct 02 2014 MannKind Corporation Mouthpiece cover for an inhaler
10625034, Apr 01 2011 MannKind Corporation Blister package for pharmaceutical cartridges
10675421, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
10751488, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
11446127, Aug 05 2013 MannKind Corporation Insufflation apparatus and methods
8424518, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
8485180, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
8499757, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
8636001, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
8912193, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9192675, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9220687, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9233159, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9241903, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
9283193, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9339615, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9358352, Jun 13 2008 MannKind Corporation Dry powder drug delivery system and methods
9364436, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
9364619, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
9393372, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
9446001, Sep 14 2005 MannKind Corporation Increasing drug affinity for crystalline microparticle surfaces
9446133, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9511198, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9610351, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9630930, Jun 12 2009 MannKind Corporation Diketopiperazine microparticles with defined specific surface areas
9655850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9662461, Jun 13 2008 MannKind Corporation Dry powder drug delivery system and methods
9675674, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
9700690, Mar 20 2002 MannKind Corporation Inhalation apparatus
9706944, Nov 03 2009 MannKind Corporation Apparatus and method for simulating inhalation efforts
9717689, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9796688, Aug 20 2004 MannKind Corporation Catalysis of diketopiperazine synthesis
9801925, Jun 29 1999 MannKind Corporation Potentiation of glucose elimination
9802012, Jul 12 2012 MannKind Corporation Dry powder drug delivery system and methods
9925144, Jul 18 2013 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
9943571, Aug 11 2008 MannKind Corporation Use of ultrarapid acting insulin
9983108, Mar 11 2009 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
D598536, Nov 23 2006 Innovata Biomed Limited Inhaler
D653326, Sep 14 2006 Glaxo Group Limited Inhaler
D653327, Mar 12 2007 Glaxo Group Limited Inhaler
D653747, Sep 14 2006 Glaxo Group Limited Inhaler
D782647, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D782648, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D782649, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D782650, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D782651, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D782652, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D782653, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783147, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory appartus
D783148, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783149, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783150, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783151, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783152, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783153, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783154, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783155, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783156, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783157, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783158, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783159, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783804, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783805, Jul 10 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783806, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783807, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D856659, Jun 26 2018 Inhaler cover
Patent Priority Assignee Title
4576157, Oct 24 1983 Oral inhalation apparatus
5482030, Jun 13 1994 Aerosol and non-aerosol spray counter
CA1185137,
D348929, Apr 03 1992 Norton Healthcare Limited Medicament inhaler
D349572, Dec 10 1992 Schering Corporation Aerosol inhaler
D370726, May 24 1994 Glaxo Group Limited Cap for an inhalation device
D395147, Aug 19 1996 Orion Corporation Combined inhaler and cover
D412744, Sep 24 1997 Innovata Biomed Limited Inhaler
EP414536B1,
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Feb 03 2000FROST, PHILLIPBAKER NORTON PHARMACEUTICALS, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0105840912 pdf
Feb 08 2000Baker Norton Pharmaceuticals, Inc.(assignment on the face of the patent)
Oct 12 2001BAKER NORTON PHARMACEUTICALS, INC IVAX RESEARCH, INC CHANGE OF NAME SEE DOCUMENT FOR DETAILS 0149900943 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule